Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Pemetrexed Disodium and Either Gemcitabine or Carboplatin in Treating Patients With Advanced Malignant Pleural Mesothelioma
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Malignant Mesothelioma |
| Start Date: | November 1, 2005 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00101283 |
| Study Type: | Interventional |
| Intervention: | Drug: carboplatin/Drug: gemcitabine hydrochloride/Drug: pemetrexed disodium |
| Study Design: | Treatment/Randomized/Active Control |
| Results: | No Results Available |
| Sponsors: | Eastern Cooperative Oncology Group/National Cancer Institute (NCI)/North Central Cancer Treatment Group |
| Ages: | Adult/Senior |
| Enrollment: | 32 |
| Funded By: | NETWORK/NIH |
| First Received: | January 7, 2005 |
| End Date: | January 1, 1900 |
| Last Updated: | April 14, 2009 |
| Last Verified: | October 1, 2008 |